Old Web
English
Sign In
Acemap
>
Paper
>
Liposomal doxorubicin tlc d99 in experimental and clinical breast cancer is effective and less toxic
Liposomal doxorubicin tlc d99 in experimental and clinical breast cancer is effective and less toxic
1991
G. Batist
Leonard W. Mayer
F. Pilkiewicz
T. Wang
M. Skrutkowska
A. Zukiwski
P. Ahlgren
J Skelton
P. Grunger
B Leyland-Jones
Keywords:
Breast cancer
Cancer research
Liposomal Doxorubicin
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]